| |
| |
| Exchange: |
Nasdaq National Market |
| Security
Type: |
Common |
| Shares
Out: |
126,890,000 |
| Market
Cap: |
1.15(B) |
| Last
Volume: |
0 |
Avg
Vol: |
0 |
| 52
Week Range: |
$9.05 - $9.1 |
|
| Level
I Sector: |
Health Care |
| Level
II Sector: |
Drugs |
| Level
III Sector: |
Biotechnology |
|
Member Indexes:
|
| |
NASDAQ BIOTECHNOLOGY |
|
NASDAQ COMPOSITE |
| |
NASDAQ NNM COMPOSITE |
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile CTI BioPharma is a biopharmaceutical company focused on the acquisition, development and commercialization of targeted therapies for blood-related cancers where there is an unmet medical need. Co. has one commercially approved product, VONJO™ (pacritinib), which has received approval in the U.S. by the U.S. Food and Drug Administration for the treatment of adult patients with intermediate or primary or secondary (post-polycythemia vera or post-essential thrombocythemia) myelofibrosis with a platelet count below 50 x 10^9/L.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
5,000 |
| Total Buy Value |
$0 |
$0 |
$0 |
$27,500 |
| Total People Bought |
0 |
0 |
0 |
1 |
| Total Buy Transactions |
0 |
0 |
0 |
1 |
| Total Shares Sold |
0 |
0 |
0 |
9,850,628 |
| Total Sell Value |
$0 |
$0 |
$0 |
$60,226,858 |
| Total People Sold |
0 |
0 |
0 |
5 |
| Total Sell Transactions |
0 |
0 |
0 |
26 |
| End Date |
2024-03-10 |
2023-12-08 |
2023-06-09 |
2022-06-09 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Love Richard L |
Director |
– • – |
2011-12-31 |
4 |
D |
$0.00 |
$0 |
D/D |
(166,109) |
416,644 |
|
- |
|
| Bauer John H |
Director |
– • – |
2011-12-31 |
4 |
D |
$0.00 |
$0 |
D/D |
(166,109) |
346,150 |
|
- |
|
| Bianco James A |
CEO |
• • – |
2011-12-29 |
4 |
AS |
$1.11 |
$11,110 |
D/D |
(10,000) |
3,782,921 |
|
- |
|
| Bianco James A |
CEO |
• • – |
2011-12-27 |
4 |
GD |
$0.00 |
$0 |
D/D |
20,000 |
3,792,921 |
|
- |
|
| Bianco James A |
CEO |
• • – |
2011-11-30 |
4 |
AS |
$1.08 |
$10,820 |
D/D |
(10,000) |
3,812,921 |
|
- |
|
| Singer Jack W |
EVP, Chief Medical Officer |
• • – |
2011-11-29 |
4 |
A |
$0.00 |
$0 |
D/D |
505,688 |
1,532,188 |
|
- |
|
| Philips Craig |
President |
• – – |
2011-11-29 |
4 |
A |
$0.00 |
$0 |
D/D |
1,011,376 |
2,561,187 |
|
- |
|
| Bianco James A |
CEO |
• • – |
2011-11-29 |
4 |
A |
$0.00 |
$0 |
D/D |
1,685,626 |
3,822,921 |
|
- |
|
| Eramian Daniel G |
EVP, Corporate Communication |
• – – |
2011-11-29 |
4 |
A |
$0.00 |
$0 |
D/D |
505,688 |
1,258,315 |
|
- |
|
| Bianco Louis A |
EVP, Finance & Administration |
• – – |
2011-11-29 |
4 |
A |
$0.00 |
$0 |
D/D |
505,688 |
1,492,623 |
|
- |
|
| Tuckson Reed Vaughn |
Director |
– • – |
2011-11-29 |
4 |
A |
$0.00 |
$0 |
D/D |
187,292 |
208,625 |
|
- |
|
| Love Richard L |
Director |
– • – |
2011-11-29 |
4 |
A |
$0.00 |
$0 |
D/D |
187,292 |
582,753 |
|
- |
|
| Telling Fred |
Director |
– • – |
2011-11-29 |
4 |
A |
$0.00 |
$0 |
D/D |
187,292 |
476,109 |
|
- |
|
| Gregorian Vartan |
Director |
– • – |
2011-11-29 |
4 |
A |
$0.00 |
$0 |
D/D |
187,292 |
523,113 |
|
- |
|
| Nudelman Phillip M Phd |
Director |
– • – |
2011-11-29 |
4 |
A |
$0.00 |
$0 |
D/D |
280,938 |
677,581 |
|
- |
|
| Bauer John H |
Director |
– • – |
2011-11-29 |
4 |
A |
$0.00 |
$0 |
D/D |
187,292 |
512,259 |
|
- |
|
| Mundinger Mary Oneil |
Director |
– • – |
2011-11-29 |
4 |
A |
$0.00 |
$0 |
D/D |
187,292 |
523,099 |
|
- |
|
| Nudelman Phillip M Phd |
Director |
– • – |
2011-11-11 |
4 |
A |
$0.00 |
$0 |
D/D |
3,333 |
396,643 |
|
- |
|
| Gregorian Vartan |
Director |
– • – |
2011-11-11 |
4 |
A |
$0.00 |
$0 |
D/D |
3,333 |
335,821 |
|
- |
|
| Tuckson Reed Vaughn |
Director |
– • – |
2011-11-11 |
4 |
A |
$0.00 |
$0 |
D/D |
3,333 |
21,333 |
|
- |
|
| Mundinger Mary Oneil |
Director |
– • – |
2011-11-11 |
4 |
A |
$0.00 |
$0 |
D/D |
3,333 |
335,807 |
|
- |
|
| Telling Fred |
Director |
– • – |
2011-11-11 |
4 |
A |
$0.00 |
$0 |
D/D |
3,333 |
288,817 |
|
- |
|
| Love Richard L |
Director |
– • – |
2011-11-11 |
4 |
A |
$0.00 |
$0 |
D/D |
3,333 |
395,461 |
|
- |
|
| Bauer John H |
Director |
– • – |
2011-11-11 |
4 |
A |
$0.00 |
$0 |
D/D |
3,333 |
324,967 |
|
- |
|
| Bianco James A |
CEO |
• • – |
2011-10-28 |
4 |
AS |
$1.26 |
$31,550 |
D/D |
(25,000) |
2,137,295 |
|
- |
|
742 Records found
|
|
Page 16 of 30 |
|
|
